- Report
- December 2022
Estonia
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Belarus
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Lithuania
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Latvia
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Kazakhstan
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Denmark
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Czech Republic
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Cyprus
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Croatia
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Sweden
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Slovenia
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Slovakia
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Serbia
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Norway
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Netherlands
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Moldova
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Malta
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Ireland
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Iceland
From €2286EUR$2,500USD£1,946GBP
- Report
- December 2022
Hungary
From €2286EUR$2,500USD£1,946GBP

Cryptosporidium is a genus of protozoan parasites that cause the diarrheal disease cryptosporidiosis. Infectious disease testing for Cryptosporidium is used to diagnose and monitor the disease in humans and animals. Tests for Cryptosporidium are available in a variety of formats, including immunoassays, molecular assays, and microscopy. Immunoassays are the most commonly used tests for Cryptosporidium, as they are rapid, sensitive, and specific. Molecular assays are more sensitive than immunoassays, but they are more expensive and require specialized equipment. Microscopy is the most sensitive test for Cryptosporidium, but it is labor-intensive and requires skilled personnel.
The Cryptosporidium market is a growing segment of the infectious disease testing market. The increasing prevalence of Cryptosporidium infections, the availability of new diagnostic tests, and the growing demand for rapid and accurate diagnosis are driving the growth of the market.
Companies in the Cryptosporidium market include Abbott Laboratories, Bio-Rad Laboratories, Cepheid, DiaSorin, Hologic, and Roche Diagnostics. Show Less Read more